THAR PHARMACEUTICALS, INC. Patent applications |
Patent application number | Title | Published |
20160016982 | CRYSTALLIZATION METHOD AND BIOAVAILABILITY - Preparation and in vitro and in vivo characterization of novel forms of active pharmaceutical ingredients, suitable for pharmaceutical compositions in drug delivery systems for humans. | 01-21-2016 |
20150306116 | NOVEL ORAL FORMS OF A PHOSPHONIC ACID DERIVATIVE - Novel solution complexes of zoledronic acid are described which give rise to improved properties of zoledronic acid. The invention includes aqueous solution and molecular complexes of zoledronic acid with and optical isomers of asparagine, histidine, arginine and proline as well as pharmaceutical complexes containing them and methods of treatment using them. | 10-29-2015 |
20140107076 | CRYSTALLIZATION METHOD AND BIOAVAILABILITY - Preparation, in-vitro and in vivo characterization of novel forms of (1-hydroxy-2-imidazol-1-yl-1-phosphono-ethyl)phosphonic acid, suitable for pharmaceutical compositions in drug delivery systems for humans. | 04-17-2014 |
20140100233 | CRYSTALIZATION OF PHARMACEUTICAL COMPOUNDS - Novel crystalline forms of tadalafil suitable for pharmaceutical compositions in drug delivery systems for humans. | 04-10-2014 |
20140057875 | CRYSTALLIZATION METHOD AND BIOAVAILABILITY - Preparation, in-vitro and in vivo characterization of novel forms of (1-hydroxy-2-imidazol-1-yl-1-phosphono-ethyl)phosphonic acid, suitable for pharmaceutical compositions in drug delivery systems for humans. | 02-27-2014 |
20130316982 | NOVEL CRYSTALLINE FORMS - Preparation and characterization of novel forms of (1-hydroxy-2-imidazol-1-yl-1-phosphono-ethyl) phosphonic acid, suitable for pharmaceutical compositions in drug delivery systems for humans. | 11-28-2013 |
20110028435 | CRYSTALLIZATION METHOD AND BIOAVAILABILITY - Preparation, in-vitro and in vivo characterization of novel forms of (1-hydroxy-2-imidazol-1-yl-1-phosphono-ethyl)phosphonic acid, suitable for pharmaceutical compositions in drug delivery systems for humans. | 02-03-2011 |
20080280858 | METHOD OF CREATING CRYSTALLINE SUBSTANCES - Process for preparing a cocrystal of an active substance and a cocrystal former, the process involving precipitating the active substance and the cocrystal former together from solution or suspension, in the presence of a supercritical or near-critical fluid, in particular using a GAS, SAS, SEDS or SAS-EM process. The invention also provides a cocrystal prepared using such a process, and its use as a seed crystal in a subsequent process for precipitating a cocrystal of an active substance and a cocrystal former. | 11-13-2008 |